Narayana Hrudayalaya Limited (NSE: NH, BSE: 539551) is a Bengaluru, Karnataka-based company in the Assisted Living Facilities and Services industry. With a market capitalisation of ₹34,921 Cr, it ranks #251 by market cap among the 6,137 Indian listed companies on FinBizNet, and #1 of 4 in Assisted Living Facilities and Services. At ₹1,646.90 (as of 25 Oct 2026), the share price is 21.3% below its 52-week high of ₹2,093.30 and 3.6% above its 52-week low of ₹1,589.00. The share price is down 6.7% over one year and down 16.0% over three months.
| Current Price | ₹1,646.90 |
|---|---|
| Market Cap | ₹34,921 Cr |
| NSE Symbol | NH |
| BSE Code | 539551 |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Facilities > Assisted Living Facilities and Services |
| P/E Ratio | 43.4 |
| Return on Equity | 19.85% |
| Return on Assets | 7.40% |
| 52-Week Range | ₹1,589.00 – ₹2,093.30 |
| 1-Year Price Change | -6.7% |
| 3-Month Price Change | -16.0% |
| Beta (1Y) | 0.12 |
| Dividend Yield | 0.26% |
| Headquarters | Bengaluru, Karnataka |
| Website | www.narayanahealth.org |
| Revenue | ₹2,684 Cr |
|---|---|
| Net Profit | ₹207 Cr |
| Net Margin | 7.7% |
| EPS (Basic) | ₹10.20 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Narayana Hrudayalaya Limited provides medical and healthcare services in India and the Cayman Islands. It operates through the Medical and Healthcare Related Services; and Others segments. The company offers oncology, anesthesiology, audiology, blood bank, oncoplastic surgery, cardiac surgery, cardiology, clinical genetics, clinical immunology, clinical nutrition and dietetics, clinical psychology, congenital adult heart disease, cosmetology, cranio-maxillofacial surgery, critical care medicine, dental, dermatology, pediatrics, diabetology, ENT, emergency medicine, endocrinology, family medicine, general and GI surgery, general medicine and surgery, geriatric medicine, gynecology, hematology, headache and facial pain management, transplant, infectious diseases, neurology, radiology, hepatobiliary surgery, gastroenterology, minimal access GI and bariatric surgery, neonatology, nephrology, neuro-otology, neuro-rehabilitation, neurosurgery and spine surgery, and nuclear medicine services.
1. Medical and Healthcare Services-This segment operates a network of multispecialty and superspeciality hospitals that offer medical and healthcare services.
1. Medical and Healthcare Related Services-95.7% 2. Others-4.8%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Narayana Hrudayalaya Limited | ₹34,921 Cr | 43.4 | 19.85% | ₹2,684 Cr | -6.7% |
| Shalby Ltd | ₹1,386 Cr | 36.3 | 3.47% | ₹331 Cr | -55.1% |
| Max India Ltd | ₹889 Cr | -6.5 | -31.77% | ₹60 Cr | -28.9% |
| N.G.Industries Ltd | ₹35 Cr | 20.3 | 4.81% | — | -29.2% |
Listed by market capitalisation. Ratios are shown for context only.
Narayana Hrudayalaya Limited is trading at ₹1,646.90, with a market capitalisation of ₹34,921 Cr.
Narayana Hrudayalaya Limited operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Facilities > Assisted Living Facilities and Services).
Narayana Hrudayalaya Limited has a P/E of 43.4 and a return on equity of 19.85%.
Narayana Hrudayalaya Limited is listed on the NSE under the symbol NH and on the BSE under the scrip code 539551.
Narayana Hrudayalaya Limited's share price is down 6.7% over one year and down 16.0% over three months. Its 52-week range is ₹1,589.00 to ₹2,093.30.
In Q1 FY27, Narayana Hrudayalaya Limited reported revenue of ₹2,684 Cr and net profit of ₹207 Cr, with basic EPS of ₹10.2 (consolidated, parsed from the company's exchange filing).
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.